Michael C. Quirk

Insider Reports History

Entity
Individual
Location
C/O Sage Therapeutics, Inc., 55 Cambridge Parkway, Cambridge, MA
Signature
Brandon Marsh, attorney in fact for Michael C. Quirk
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael C. Quirk:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Sage Therapeutics, Inc. Chief Scientific Officer and Interim Head of R&D Common Stock 30.6K $211K $6.91 Apr 10, 2025 Direct
Sage Therapeutics, Inc. Chief Scientific Officer and Interim Head of R&D S 4K Apr 1, 2025 Direct

Insider Reports Filed by Michael C. Quirk

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SAGE Sage Therapeutics, Inc. Apr 10, 2025 4 -$5.09K 4 Apr 11, 2025 Chief Scientific Officer and Interim Head of R&D
SAGE Sage Therapeutics, Inc. Apr 1, 2025 2 $0 4 Apr 2, 2025 Chief Scientific Officer and Interim Head of R&D
SAGE Sage Therapeutics, Inc. Apr 1, 2025 0 $0 3 Apr 2, 2025 Chief Scientific Officer and Interim Head of R&D